Clinical trials
Secondary Prevention clinical trials
Below are recruiting secondary prevention clinical trials, each written for real people, not researchers. We’re tracking 41 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06783049Recruiting
Smartphone help to prevent another stroke after recent stroke or TIA
This trial tests a smartphone-based system that helps people who recently had a stroke or TIA manage their risk factors like high blood pressure or diabetes after leaving the hospital. It's designed to see if this tool can prevent another stroke.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07407790Recruiting
Smartphone heart check after stroke
This study tests whether using a smartphone app to check your heart rhythm after a stroke can find hidden atrial fibrillation (an irregular heartbeat). If you had a recent stroke or TIA and are not already on blood thinners, you may be able to help doctors detect and prevent future strokes.
KristiansandAges 18 years+ - NCT07432438Recruiting
Online suicide prevention training for school counselors
This trial tests an online training program to help secondary school counselors better prevent and respond to suicide risk among students. If you work as a counselor in a middle or high school and have the technology to join online sessions, this study may help you build important skills.
AydinAges 18 years+ - NCT07001735Recruiting
Talking for Change: Preventing child sexual abuse before it happens
This study tests a program called 'Talking for Change' to help people who are worried they might sexually harm a child. It offers group therapy and support to reduce that risk.
Toronto, OntarioAges 18 years+ - NCT07542860Recruiting
Comparing two aspirin doses in older heart disease patients
This study compares whether a lower dose of aspirin (50 mg) works as well as a standard dose (100 mg) for older adults who have had heart attacks, strokes, or other heart and blood vessel problems. The goal is to find the safest effective dose to prevent future events.
BeijingAges 60 years+ - NCT07521436Recruiting
Understanding Heart Disease Risk Awareness in Men and Women
This study asks people who have had heart or blood vessel problems about their understanding of risk factors and how they view their cardiovascular health. Researchers want to learn whether men and women perceive their heart disease risk differently.
MilanAges 18 years+ - NCT07259278Recruiting
Heart rehab program with smart app support
This trial uses a smartphone app to guide exercise for people with coronary heart disease who are at low risk of complications. It aims to help you recover safely at home with remote support from doctors.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07233863Recruiting
Lymphovenous bypass for preventing lymphedema in breast cancer
This trial tests a surgery (lymphovenous bypass) to prevent or slow down lymphedema (arm swelling) in breast cancer patients who have already had lymph nodes removed. It may help those with early-stage lymphedema who haven't tried physical therapy yet.
Jakarta, Jakarta Special Capital RegionAges 18 years+ - NCT06926751RecruitingPhase 2
Preventing low white blood cell counts in kids with solid tumors
This trial compares two drugs (Telpegfilgrastim and Filgrastim) to help prevent dangerously low white blood cell counts after chemotherapy in children and young adults with solid tumors. It's for patients who have already had this problem in a previous chemo round.
BeijingAges 6–24 - NCT04796350Recruiting
Medicine after hip surgery to help prevent a second hip fracture
This trial tests AGN1 LOEP (a medicine/device placed at the hip surgery site) to help prevent another hip fracture after you’ve had a low-energy hip fracture. You must be eligible for hip repair surgery and be at higher risk for another fracture, with no key exclusions like active cancer or serious kidney disease.
InnsbruckAges 65–91 - NCT07031089Recruiting
City-Hospital Collaboration for Early Liver Fibrosis Detection
This study looks at whether a city-hospital partnership can help find liver fibrosis (early scarring of the liver) earlier in people who get a Fibroscan test ordered by their primary care doctor. It is for adults whose Fibroscan result was at least 8 kPa and who had the test between 2023 and 2026.
GrenobleAges 18 years+ - NCT06979609RecruitingPhase 2/Phase 3
Preventing C. diff infection with vancomycin
This trial tests whether taking vancomycin by mouth can prevent another C. diff infection when you need to take other antibiotics. It’s for patients who recently had C. diff and are about to start a new antibiotic course.
Montreal, QuebecAges 18 years+ - NCT07581808RecruitingPhase 4
Two cholesterol drugs for heart disease prevention
This study tests two newer cholesterol-lowering medications (inclisiran and alirocumab) together in people who've had heart problems or strokes and cannot tolerate standard cholesterol drugs. The goal is to see if this combination safely lowers cholesterol further and reduces future cardiovascular events.
LjubljanaAges 18 years+ - NCT06845410Recruiting
INR-CAD: inflammation-related coronary artery disease study
This study follows people who have both coronary artery disease (narrowed heart arteries) and signs of chronic inflammation to learn more about their condition, current treatments, and outcomes. It helps doctors understand how best to care for patients like you.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06837311Recruiting
Smoking cessation after stroke via smartphone monitoring
This study tests a smartphone-based program that helps people who recently had a stroke quit smoking. It uses digital monitoring and support as part of your regular post-stroke follow-up to lower the risk of another stroke.
BordeauxAges 18–80 - NCT06763055RecruitingPhase 3
Study of two drugs for spontaneous brain bleed recovery
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
Sydney, New South WalesAges 18–80 - NCT06738381Recruiting
Digital prevention program after heart attack or stroke
This trial tests a digital program (using a smartphone or tablet) to help prevent another heart attack or stroke. It is for people who have already had a heart-related event or have known artery plaque buildup.
Drammen, BuskerudAges 18 years+ - NCT06732310Enrolling by invitationPhase 2
Prenatal and early childhood program to reduce child maltreatment
This study tests whether a program that starts during pregnancy and continues after birth can help reduce child abuse and neglect. It looks at how these programs work for mothers who have experienced intimate partner violence.
Notre Dame, IndianaAges 3 years+ - NCT06714097Recruiting
Digital twin technology for stroke and related conditions
This trial tests a digital twin system to help prevent a second stroke or brain bleed in people with stroke, Moyamoya disease, or cerebral amyloid angiopathy. The system uses your medical data to create a virtual copy of you, which doctors can use to plan your care.
Milan, MichiganAges 18 years+ - NCT06649240Recruiting
Optimal LDL cholesterol goal for small vessel stroke
This trial compares different LDL cholesterol targets after a small vessel stroke to find the best level for preventing another stroke. If you've had this type of stroke, you may be able to help doctors decide the right treatment goal.
AnsanAges 19 years+ - NCT06637657Recruiting
Optimizing long-term heart disease prevention
This trial tests different ways to manage and reduce the risk of future heart problems in people who have already had a heart attack or a procedure to open blocked heart arteries. The goal is to find the best long-term treatment plan to keep you healthy.
AmsterdamAges 18 years+ - NCT06615609Recruiting
Heart health management after bypass or stent
This trial tests a smartphone-based program to help people manage their blood pressure, blood sugar, and cholesterol after heart procedures like bypass surgery or stenting. It aims to improve long-term heart health.
Ürümqi, XinjiangAges 18 years+ - NCT06603870RecruitingPhase 4
Preventing repeat blood clots from IV catheters in cancer patients
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
Ottawa, OntarioAges 18 years+ - NCT07590635Recruiting
Heart Recovery Program Using Online Health Tools
This study tests a new heart rehabilitation program that combines online tools with personalized support for people who've had heart procedures. It aims to help you recover safely and manage your heart health from home.
BergenAges 18 years+
Hear when a new Secondary Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for secondary prevention?
- Yes. Clin2 currently lists 41 recruiting secondary prevention studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a secondary prevention trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a secondary prevention trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.